33 related articles for article (PubMed ID: 276621)
1. Mechanisms of DNA-reactive and epigenetic chemical carcinogens: applications to carcinogenicity testing and risk assessment.
Kobets T; Iatropoulos MJ; Williams GM
Toxicol Res (Camb); 2019 Mar; 8(2):123-145. PubMed ID: 30997017
[TBL] [Abstract][Full Text] [Related]
2. Distribution of lymphoid nodules, aberrant crypt foci and tumours in the colon of carcinogen-treated rats.
Cameron IL; Garza J; Hardman WE
Br J Cancer; 1996 Apr; 73(7):893-8. PubMed ID: 8611402
[TBL] [Abstract][Full Text] [Related]
3. The persistence and phenotypic stability of transplanted rat liver neoplastic nodules.
Williams GM; Ohmori T; Watanabe K
Am J Pathol; 1980 Apr; 99(1):1-12. PubMed ID: 7361853
[TBL] [Abstract][Full Text] [Related]
4. Initiation and promotion in cancer formation: the importance of studies on intercellular communication.
Potter VR
Yale J Biol Med; 1980; 53(5):367-84. PubMed ID: 7013284
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic effects of liver tumor promoters and implications for health effects.
Williams GM
Environ Health Perspect; 1983 Apr; 50():177-83. PubMed ID: 6873012
[TBL] [Abstract][Full Text] [Related]
6. Light- and electron-microscopic autoradiographic analysis of proliferating cells during the early stages of chemical hepatocarcinogenesis in the rat induced by feeding N-2-fluorenylacetamide in a choline-deficient diet.
Sell S; Salman J
Am J Pathol; 1984 Feb; 114(2):287-300. PubMed ID: 6696045
[TBL] [Abstract][Full Text] [Related]
7. Promoting effect of polychlorinated biphenyls on development of enzyme-altered islands in livers of weanling and adult rats.
Oesterle D; Deml E
J Cancer Res Clin Oncol; 1983; 105(2):141-7. PubMed ID: 6402515
[TBL] [Abstract][Full Text] [Related]
8. Non-persisting early foci of altered hepatocytes induced in rats by N-nitrosomorpholine.
Enzmann H; Bannasch P
J Cancer Res Clin Oncol; 1988; 114(1):30-4. PubMed ID: 3350840
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats.
Tanaka T; Iwata H; Niwa K; Mori Y; Mori H
Jpn J Cancer Res; 1988 Dec; 79(12):1297-303. PubMed ID: 2906931
[TBL] [Abstract][Full Text] [Related]
10. Connection of ductlike structures induced by a chemical hepatocarcinogen to portal bile ducts in the rat liver detected by injection of bile ducts with a pigmented barium gelatin medium.
Dunsford HA; Maset R; Salman J; Sell S
Am J Pathol; 1985 Feb; 118(2):218-24. PubMed ID: 2578739
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation induced in the kidneys and livers of rats and mice by short term exposure to the carcinogen p-dichlorobenzene.
Umemura T; Tokumo K; Williams GM
Arch Toxicol; 1992; 66(7):503-7. PubMed ID: 1359854
[TBL] [Abstract][Full Text] [Related]
12. The stem cells of the liver--a selective review.
Aterman K
J Cancer Res Clin Oncol; 1992; 118(2):87-115. PubMed ID: 1346535
[TBL] [Abstract][Full Text] [Related]
13. The resistance of spontaneous mouse hepatocellular neoplasms to iron accumulation during rapid iron loading by parenteral administration and their transplantability.
Williams GM; Hirota N; Rice JM
Am J Pathol; 1979 Jan; 94(1):65-74. PubMed ID: 760541
[TBL] [Abstract][Full Text] [Related]
14. Application of fine-needle aspiration biopsy for the diagnosis of dysplastic and neoplastic liver cell changes induced by N-nitrosomorpholine in rats.
Boelsterli U; Zbinden G
Arch Toxicol; 1979 Sep; 42(4):225-38. PubMed ID: 42375
[TBL] [Abstract][Full Text] [Related]
15. Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen.
Williams GM; Watanabe K
J Natl Cancer Inst; 1978 Jul; 61(1):113-21. PubMed ID: 276621
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions.
Watanabe K; Williams GM
J Natl Cancer Inst; 1978 Nov; 61(5):1311-4. PubMed ID: 280716
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural abnormalities in carcinogen-induced hepatocellular altered foci identified by resistance to iron accumulation.
Hirota N; Williams GM
Cancer Res; 1982 Jun; 42(6):2298-309. PubMed ID: 7074612
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities in liver iron accumulation during N-2-fluorenylacetamide hepatocarcinogenesis that are dependent or independent of continued carcinogen action.
Furuya K; Maeura Y; Williams GM
Toxicol Pathol; 1984; 12(2):136-42. PubMed ID: 11478314
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
